文献速递姑息放疗与转移瘤放疗物理与技术

患者门户消息与放射肿瘤患者生存的关联

Association of Patient Portal Messaging with Survival Among Radiation Oncology Patients.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-05-08

这项回顾性队列研究纳入2014年1月14日至2023年4月23日在加州大学旧金山分校接受放射肿瘤诊疗的25367例患者,分析门户消息与生存的关联。调整社会经济、疾病和治疗特征后,患者向放射肿瘤提供者发送消息(HR 0.90)和接收提供者消息(HR 0.77)均与生存相关。研究还发现黑人、医疗补助参保者等群体在消息发送和接收上存在差异。

要点

  • 患者向放射肿瘤提供者发送消息与生存相关(HR 0.90,95%CI 0.84-0.96,P=.001)。
  • 放射肿瘤提供者向患者发送消息与生存相关(HR 0.77,95%CI 0.70-0.84,P<.001)。
  • 黑人患者和医疗补助参保者发送和接收门户消息的比值比较低。

核心结论

  • 患者向放射肿瘤提供者发送门户消息和接收放射肿瘤提供者发送的门户消息均与更好的生存相关。
  • 未来研究应阐明如何最好地支持患者和提供者的参与。

研究设计与样本

  • 回顾性队列研究,纳入2014年1月14日至2023年4月23日在加州大学旧金山分校接受放射肿瘤诊疗的至少21岁患者。
  • 共纳入25367例患者,中位年龄64岁(四分位距54-72),13175例(52%)为白人,14389例(57%)为男性。
  • 采用Cox比例风险模型分析死亡结局,采用逻辑回归模型分析与门户消息相关的因素。

主要发现

  • 作为消息线程中的第一条消息,8986例(35%)患者向放射肿瘤提供者发送消息,4218例(17%)患者接收放射肿瘤提供者发送的消息。
  • 头颈部或泌尿生殖系统恶性肿瘤患者比其他诊断患者更可能向放射肿瘤提供者发送消息和接收放射肿瘤提供者发送的消息。
  • 调整社会经济、疾病和治疗特征后,患者向放射肿瘤提供者发送消息与生存相关(HR 0.90;95%CI 0.84-0.96;P=.001)。
  • 调整后,放射肿瘤提供者向患者发送消息与生存相关(HR 0.77;95%CI 0.70-0.84;P<.001)。
  • 患者向放射肿瘤提供者发送消息存在差异:黑人 vs 白人(OR 0.60;95%CI 0.51-0.69;P<.001),医疗补助 vs 医疗保险(OR 0.70;95%CI 0.62-0.79;P<.001)。

关键数值与推荐

  • 患者向放射肿瘤提供者发送消息与生存的关联:HR 0.90(95%CI 0.84-0.96;P=.001)。
  • 放射肿瘤提供者向患者发送消息与生存的关联:HR 0.77(95%CI 0.70-0.84;P<.001)。
  • 黑人 vs 白人患者向放射肿瘤提供者发送消息的OR 0.60(95%CI 0.51-0.69;P<.001)。
  • 医疗补助 vs 医疗保险患者向放射肿瘤提供者发送消息的OR 0.70(95%CI 0.62-0.79;P<.001)。
  • 接收放射肿瘤提供者消息的差异:黑人 vs 白人OR 0.77(95%CI 0.64-0.91;P=.003),医疗补助 vs 医疗保险OR 0.76(95%CI 0.65-0.89;P<.001),女性 vs 男性提供者OR 1.47(95%CI 1.34-1.62;P<.001)。

临床怎么用

  • 患者向放射肿瘤提供者发送门户消息和接收放射肿瘤提供者发送的门户消息均与更好的生存相关。
  • 未来研究应阐明如何最好地支持患者和提供者的参与。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The shift to electronic health records has led to both patient portal messaging and large amounts of digital, real-world data for research. The objective of this study was to examine the association between portal messaging and survival among radiation oncology patients, using real-world data. METHODS AND MATERIALS: This retrospective cohort study included patients at least 21 years old and seen by radiation oncology providers between January 14, 2014, and April 23, 2023, at the University of California, San Francisco. We developed Cox proportional hazards models for the outcome of death and examined factors associated with portal messaging using logistic regression models. RESULTS: Among 25,367 patients, the median age was 64 (interquartile range [IR], 54-72), 13,175 (52%) were White, and 14,389 (57%) were male. Overall, as the first message in a thread, 8986 (35%) patients sent messages to radiation oncology providers, and 4218 (17%) patients were sent messages from radiation oncology providers. Patients with head and neck or genitourinary malignancies were more likely than those with other diagnoses to send portal messages to and be sent portal messages from radiation oncology providers. Both sending portal messages to radiation oncology providers (hazard ratio [HR], 0.90; 95% confidence interval [CI], 0.84-0.96; P = .001) and being sent messages from radiation oncology providers (HR, 0.77; CI, 0.70-0.84; P < .001) as the first message in a thread were associated with patient survival after adjusting for socioeconomic, disease, and treatment characteristics. There were disparities among patients sending portal messages to radiation oncology providers, including for Black versus White patients (odds ratio [OR], 0.60; CI, 0.51-0.69; P < .001) and for Medicaid versus Medicare patients (OR, 0.70; CI, 0.62-0.79; P < .001). There were also disparities among patients being sent portal messages by radiation oncology providers, including for Black versus White patients (OR, 0.77; CI, 0.64-0.91; P = .003), for Medicaid versus Medicare patients (OR, 0.76; CI, 0.65-0.89; P < .001), and for patients with female versus male providers (OR, 1.47; CI 1.34-1.62; P < .001). CONCLUSIONS: Sending portal messages to and being sent portal messages from radiation oncology providers were associated with better survival. Future studies should elucidate how best to support patient and provider engagement.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Alexander J, Beatty A. Association of Patient Portal Messaging with Survival Among Radiation Oncology Patients. Int J Radiat Oncol Biol Phys. 2024. PMID: 38723754. doi:10.1016/j.ijrobp.2024.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。